Investor Relations

20191024 AIMS PerioTrap 179

Publicly funded programs

bmbf 2 – PerioTrap

KMUi-Biomedicine-1: Development and preclinical qualification of novel periodontitis therapeutics for clinical use (ParoPaste) – Research into and preclinical qualification of novel periodontitis therapeutics in proof-of-concept models and regulatory preparation for clinical use

EU co-funded projects (ERDF)

sachen anhalt efre – PerioTrap

Alternative metal-binding groups in drugs for the treatment of periodontitis - AMePA

sachen anhalt efre – PerioTrap

Controlled-release drug delivery systems using innovative and selective drug molecules for the treatment of bacterial infections of the periodontium – ParoStop

sachen anhalt efre – PerioTrap

Profiling inhibitors of bacterial glutaminyl cyclases as drug prototypes for novel periodontal therapeutics – PInParo